Serum Institute of India

	Serum Institute to produce additional 100 million COVID-19 vaccine doses for India, other countries Its latest collaboration along with Gavi and the Bill and Melinda Gates Foundation brings the total number of vaccine doses to be covered to an aggregate of up to 200 million doses. published on : 29th September 2020
	Phase-III human clinical trial of Oxford COVID-19 vaccine begins in Pune Under phase-II, trials had been conducted at the Bharti Vidyapeeth Medical College and also KEM Hospital in the city. published on : 21st September 2020
	Phase-III trial of Oxford vaccine to begin in Pune next week Under phase-II, trials were conducted at Bharti Vidyapeeth Medical College and also KEM Hospital in the city. published on : 20th September 2020
	Serum Institute of India gets DCGI nod to resume clinical trial of Oxford COVID-19 vaccine SII has also been asked to submit to the DCGI's office details of medication used in accordance with the protocol for management of adverse events. published on : 16th September 2020
	DCGI orders Serum Institute of India to suspend recruitment for Oxford COVID-19 vaccine trials Earlier this week, AstraZeneca said it had paused the trials because of 'an unexplained illness' in a participant in the study published on : 12th September 2020
	Will adhere to DCGI instructions: Serum Institute on show cause over not pausing trial of COVID-19 vaccine The Serum Institute said in its statement that they were not instructed to pause trials. published on : 10th September 2020
	DCGI sends show-cause notice to Serum Institute for not pausing trial of COVID-19 vaccine The drug regulator's move comes after AstraZeneca, which is developing the vaccine candidate against COVID-19 with researchers of Oxford University published on : 9th September 2020
	Phase 2 trial of Oxford COVID-19 vaccine candidate set to begin from Tuesday Serum Institute of India has partnered with British-Swedish pharma company AstraZeneca for manufacturing the COVID-19 vaccine candidate, developed by the University of Oxford. published on : 25th August 2020
	If everything goes well India would get COVID-19 vaccine by year-end: Harsh Vardhan Three COVID-19 vaccine candidates, including two indigenous ones, are in different phases of development in India. published on : 24th August 2020
	Oxford Covid-19 vaccine to cost Rs 225 per dose in India: Serum Institute The vaccine candidate is under advanced stages of clinical trials and likely to be available for public use in the first half of 2021. published on : 7th August 2020
	COVID-19 vaccine: Serum Institute to produce up to 100 million doses for India, other countries The company has set an affordable ceiling price of USD 3 (around Rs 225) per dose, it added. published on : 7th August 2020
	DCGI asks Serum Institute to revise protocol for phase 2, 3 trials of Oxford COVID-19 vaccine The SEC on COVID-19 which held its meeting on Tuesday deliberated on the application by SII and asked the Pune-based firm to revise its protocol for the phase 2 and 3 clinical trials. published on : 30th July 2020
	COVID-19: Serum Institute conducting phase 3 clinical trial of BCG vaccine candidate, says DBT About 6,000 health workers and high-risk individuals including those in close contact of COVID-19 patients have been enrolled in the clinical trial. published on : 27th July 2020
	Will keep enough COVID-19 vaccine doses for Parsis: Serum Institute of India CEO Adar Poonawalla, while replying to a tweet by film producer Ronnie Screwvala, however, did not specify the quantity of the doses that will be kept for the community. published on : 27th July 2020
	Serum Institute of India seeks DCGI nod for phase 2, 3 clinical trials of Oxford vaccine for COVID-19 The sources told PTI that the Pune-based drug firm submitted its application to the DCGI on Friday seeking permission for conducting the trials of the vaccine candidate 'Covishield'. published on : 25th July 2020